author-photo

Enrico Patrucco

University of Turin

23

Papers

953

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LT018: The perivascular niche protects ALK+ lymphoma cells from ALK inhibition through the CCL19/21-CCR7 axis

2021
Show All
- Source
- Cite
- Save
Citations (0)
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PO-17: Microphysiologic model of ALK+ anaplastic large cell lymphoma and vascular interactions predicts drug efficacy in a 3D microfluidic chip

2020
Show All
- Source
- Cite
- Save
Citations (0)
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

2019 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (31)
Comment on “ALK is a therapeutic target for lethal sepsis”

2018 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (3)
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

2018 Cancers
Show All
- Source
- Cite
- Save
Citations (49)
Mo1751 CGMP-Dependent Kinase 2, Na+/H+ Regulatory Factor 2, and Na+/H+ Exchanger Isoform 3 Dynamically Assemble Within Lipid Rafts in Murine Small Intestinal Brush Border Membrane

2014 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy

2013 BMC Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (2)